alphanewsstream
2021-05-07 10:45
H.C. Wainwright Reaffirms Their Buy Rating on Fulcrum Therapeutics (FULC)
H.C.
The post H.C. Wainwright Reaffirms Their Buy Rating on Fulcrum Therapeutics (FULC) appeared first on Smarter Analyst.
H.C. Wainwright analyst Andrew Fein reiterated a Buy rating on Fulcrum Therapeutics (FULC) today and set a price target of $20.00. The companys shares closed last Thursday at $...
https://www.smarteranalyst.com/new-blurbs/h-c-wainwright-reaffirms-their-buy-rating-on-fulcrum-therapeutics-fulc/
#SmarterAnalyst
The post H.C. Wainwright Reaffirms Their Buy Rating on Fulcrum Therapeutics (FULC) appeared first on Smarter Analyst.
H.C. Wainwright analyst Andrew Fein reiterated a Buy rating on Fulcrum Therapeutics (FULC) today and set a price target of $20.00. The companys shares closed last Thursday at $...
https://www.smarteranalyst.com/new-blurbs/h-c-wainwright-reaffirms-their-buy-rating-on-fulcrum-therapeutics-fulc/
#SmarterAnalyst
You must login before you can post a comment.